Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Sirot

Showing results (41-50 of 96) with videos related to

Pageof 10
Sort By:
Gene|May 30, 1989
Characterization of the plasmid genes blaT-4 and blaT-5 which encode the broad-spectrum beta-lactamases TEM-4 and TEM-5 in enterobacteriaceaeW Sougakoff, A Petit, S Goussard, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1986
A comparison of agar dilution, identification of beta-lactamases and disc diffusion methods for assessing the sensitivity to ticarcillin-clavulanic acidB Joly, M Chanal, D Sirot, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1989
Comparative study of five plasmid-mediated ceftazidimases isolated in Klebsiella pneumoniaeD Sirot, C Chanal, R Labia, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1989
Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum beta-lactamasesC Chanal, D Sirot, M Chanal, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2003
Effects of Ser130Gly and Asp240Lys substitutions in extended-spectrum beta-lactamase CTX-M-9C Aumeran, C Chanal, R Labia, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1994
Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitorsX Y Zhou, F Bordon, D Sirot, et al.
Drugs Under Experimental and Clinical Research|January 1, 1989
The kinetics of CAZ-5, a novel SHV-related plasmid-mediated beta-lactamase with enhanced hydrolytic activity against ceftazidimeR Labia, A Thabaut, A Morand, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2005
TEM-109 (CMT-5), a natural complex mutant of TEM-1 beta-lactamase combining the amino acid substitutions of TEM-6 and TEM-33 (IRT-5)F Robin, J Delmas, C Chanal, et al.
Pathologie-Biologie|April 1, 1995
[Detection of beta-lactamases resistant to inhibitors (IRT) by the disk diffusion method]J P Romaszko, L Bret, C Henquell, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2002
TEM derivative-producing Enterobacter aerogenes strains: dissemination of a prevalent cloneP Dumarche, C De Champs, D Sirot, et al.
Pageof 10

Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
Gene|May 30, 1989
Characterization of the plasmid genes blaT-4 and blaT-5 which encode the broad-spectrum beta-lactamases TEM-4 and TEM-5 in enterobacteriaceaeW Sougakoff, A Petit, S Goussard, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1986
A comparison of agar dilution, identification of beta-lactamases and disc diffusion methods for assessing the sensitivity to ticarcillin-clavulanic acidB Joly, M Chanal, D Sirot, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1989
Comparative study of five plasmid-mediated ceftazidimases isolated in Klebsiella pneumoniaeD Sirot, C Chanal, R Labia, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1989
Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum beta-lactamasesC Chanal, D Sirot, M Chanal, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2003
Effects of Ser130Gly and Asp240Lys substitutions in extended-spectrum beta-lactamase CTX-M-9C Aumeran, C Chanal, R Labia, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1994
Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitorsX Y Zhou, F Bordon, D Sirot, et al.
Drugs Under Experimental and Clinical Research|January 1, 1989
The kinetics of CAZ-5, a novel SHV-related plasmid-mediated beta-lactamase with enhanced hydrolytic activity against ceftazidimeR Labia, A Thabaut, A Morand, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2005
TEM-109 (CMT-5), a natural complex mutant of TEM-1 beta-lactamase combining the amino acid substitutions of TEM-6 and TEM-33 (IRT-5)F Robin, J Delmas, C Chanal, et al.
Pathologie-Biologie|April 1, 1995
[Detection of beta-lactamases resistant to inhibitors (IRT) by the disk diffusion method]J P Romaszko, L Bret, C Henquell, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2002
TEM derivative-producing Enterobacter aerogenes strains: dissemination of a prevalent cloneP Dumarche, C De Champs, D Sirot, et al.
Pageof 10